Specialty Pharmacy & Distribution

, Vice President, Business Development - August 16, 2012
Much like patient populations, successful launches come in all sizes.  Congratulations go to Regeneron this quarter on the success of the EYLEA® (aflibercept) Injection, which was approved by the FDA in November 2011 and is...
Tagged in:
, Vice President, Business Development - August 07, 2012
More than half of the cancer drugs newly approved in 2011 are administered orally.  Oral oncology medications make therapy more manageable and convenient for patients.  However, these therapies can pose potential challenges...
, Vice President, Business Development - July 12, 2012
Pediatricians are known for saying that children aren’t just small adults; and their healthcare needs shouldn’t be treated that way.  Giving children less of the same medicine or ordering a smaller MRI just doesn’t work. ...
HealthBridge Pharma & Biotech - July 09, 2012
Putting patients first is what we do.  It’s what we should do.  And, we don’t expect a special award for doing our job.  Still, we can’t help but brag a little -- the Patient First award we received from Corcept...
HealthBridge Pharma & Biotech - June 28, 2012
The Federal Drug Administration (FDA) Safety and Innovation Act moved one step closer to final approval this week when it was passed by Congress.  The bill is expected to be signed into law by President Obama later this summer....

Pages